Dirk Schadendorf, MD, University Hospital Essen
Advertisement
Articles by Dirk Schadendorf, MD, University Hospital Essen
Advertisement
Latest Updated Articles
Molecular Testing in Metastatic MelanomaPublished: January 22nd 2021 | Updated:
The Role of COVID-19 in Adjuvant Treatment Decisions in MelanomaPublished: January 22nd 2021 | Updated:
Looking at Approved Agents in Metastatic MelanomaPublished: January 29th 2021 | Updated:
Testing and BRAF Mutations in MelanomaPublished: January 8th 2021 | Updated:
Future Directions in Metastatic MelanomaPublished: February 5th 2021 | Updated:
A Look at the KEYNOTE-054 and COMBI-AD DataPublished: January 15th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
4
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
5